Medicortex Finland Oyj

📍 Turku, Finland🗓 Founded 2014👥 15 employees💰 Last funded Dec 2019
Biotechnology Research🌐 medicortex.fi
Website LinkedIn
Medicortex Finland Oyj is a biotechnology company dedicated to developing diagnostics and treatments for acute neurodegenerative conditions, including traumatic brain injury (TBI) and concussion. One of the company's missions is to identify a new biomarker in order to reliably assess the severity and extent of brain injury. Medicortex was founded by Dr. Adrian Harel in Turku, Finland, in 2014 and it operates as a public limited company. Dr. Harel has a track record in business management and leadership of early-stage biotechnology companies. ---- Kuvaus suomeksi: Medicortex Finland Oyj (http://www.medicortex.fi) on bioteknologian alan yritys, joka on keskittynyt parantamaan tapaturmaisten aivovammojen (TBI) diagnostiikkaa ja hoitoa. Yrityksen nykyinen painopiste on kehittää biomerkkiaineisiin perustuvaa diagnostiikkaa, jolla pystytään arvioimaan aivovamman laajuutta ja vaikeusastetta.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Sweden
1
Denmark
1
Frequently asked questions
Who invested in Medicortex Finland Oyj?
Medicortex Finland Oyj has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Medicortex Finland Oyj last raise funding?
The most recent investment in Medicortex Finland Oyj recorded on gritt.io was in December 2019.
When was Medicortex Finland Oyj founded?
Medicortex Finland Oyj was founded in 2014.
What industry is Medicortex Finland Oyj in?
Medicortex Finland Oyj operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Medicortex Finland Oyj based?
Medicortex Finland Oyj is headquartered in Turku, Finland.